Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models

Blood Cells, Molecules, and Diseases

Volumn 39, Issue 3, 2007, Pages 316-320

  DeKoter, Rodney P ^a   Kamath, Meghana B ^a   Houston, Isaac B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; TRANSCRIPTION FACTOR PU 1;

ARTICLE; B LYMPHOCYTE; CELL FATE; COLONY FORMING UNIT GM; ERYTHROID PRECURSOR CELL; GENE FUNCTION; HEMATOPOIESIS; MEGAKARYOBLAST; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; REPORTER GENE; T LYMPHOCYTE;

ALLELES; ANIMALS; HEMATOPOIESIS; LEUKEMIA, MYELOID, ACUTE; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS;

MUS;

EID: 34848823741     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.06.004     Document Type: Article

References (31)

1. Moreau-Gachelin F., Tavitian A., and Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331 (1988) 277-280
2. Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., and Maki R.A. The macrophage and B cell-specific transcription factor PU.1 is related to the Ets oncogene. Cell 61 (1990) 113-124
3. Scott E.W., Simon M.C., Anastasi J., and Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265 (1994) 1573-1577
4. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.G., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., and Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15 (1996) 5647-5658
5. Spain L.M., Guerriero A., Kunjibettu S., and Scott E.W. T cell development in PU.1-deficient mice. J. Immunol. 163 (1999) 2681-2687
6. Colucci F., Samson S.I., DeKoter R.P., Lantz O., Singh H., and Di Santo J.P. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97 (2001) 2625-2632
7. Mueller B.U., Pabst T., Osato M., Asou N., Johansen L.M., Minden M.D., Behre G., Hiddemann W., Ito Y., and Tenen D.G. Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood 100 (2002) 998-1007
8. Cook W.D., McCaw B.J., Herring C., John D.L., Foote S.J., Nutt S.L., and Adams J.M. PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Blood 104 (2004) 3437-3444
9. Walter M.J., Park J.S., Ries R.E., Lau S.K., McLellan M., Jaeger S., Wilson R.K., Mardis E.R., and Ley T.J. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12513-12518
10. Rosenbauer F., Wagner K., Kutok J.L., Iwasaki H., Le Beau M.M., Okuno Y., Akashi K., Fiering S., and Tenen D.G. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36 (2004) 624-630
11. Ross I.L., Dunn T.L., Yue X., Roy S., Barnett C.J.K., and Hume D.A. Comparison of the expression and function of the transcription factor PU.1 (SPI-1 proto-oncogene) between murine macrophages and B lymphocytes. Oncogene 9 (1994) 121-132
12. DeKoter R.P., and Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288 (2000) 1439-1441
13. Dakic A., Metcalf D., Di Rago L., Mifsud S., Wu L., and Nutt S.L. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201 (2005) 1487-1502
14. Iwasaki H., Somoza C., Shigematsu H., Duprez E.A., Iwasaki-Arai J., Mizuno S., Arinobu Y., Geary K., Zhang P., Dayaram T., Fenyus M.L., Elf S., Chan S., Kastner P., Huettner C.S., Murray R., Tenen D.G., and Akashi K. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106 (2005) 1590-1600
15. Ye M., Ermakova O., and Graf T. PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch. J. Exp. Med. 202 (2005) 1411-1422
16. Polli M., Dakic A., Light A., Wu L., Tarlinton D.M., and Nutt S.L. The development of functional B lymphocytes in conditional PU.1 knock-out mice. Blood 106 (2005) 2083-2090
17. Schweitzer B.L., and DeKoter R.P. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines. J. Immunol. 172 (2004) 144-154
18. Back J., Allman D., Chan S., and Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp. Hematol. 33 (2005) 395-402
19. Nutt S.L., Metcalf D., D'Amico A., Polli M., and Wu L. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. J. Exp. Med. 201 (2005) 221-231
20. Schuetze S., Stenberg P.E., and Kabat D. The Ets-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell. Biol. 13 (1993) 5670-5678
21. Anderson M.K., Weiss A.H., Hernandez-Hoyos G., Dionne C.J., and Rothenberg E.V. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 16 (2002) 285-296
22. Moreau-Gachelin F., Wendling F., Molina T., Denis N., Titeaux M., Grimber G., Briand P., Vainchenker W., and Tavitian A. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell. Biol. 16 (1996) 2453-2463
23. Houston I.B., Huang K.J., Jennings S.R., and DeKoter R.P. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner. Exp. Hematol. 35 (2007) 374-384
24. Houston I.B., Kamath M.B., Schweitzer B.L., Chlon T.M., and DeKoter R.P. Reduction in PU.1 activity results in a block to B cell development, abnormal myeloid proliferation, and neonatal lethality. Exp. Hematol. 35 (2007) 1056-1068
25. Rosenbauer F., Owens B.M., Yu L., Tumang J.R., Steidl U., Kutok J.L., Clayton L.K., Wagner K., Scheller M., Iwasaki H., Liu C., Hackanson B., Akashi K., Leutz A., Rothstein T.L., Plass C., and Tenen D.G. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38 (2006) 27-37
26. Fisher R.C., Olson M.C., Pongubala J.M., Perkel J.M., Atchison M.L., Scott E.W., and Simon M.C. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain. Mol. Cell. Biol. 18 (1998) 4347-4357
27. Tondravi M.M., McKercher S.R., Anderson K., Erdmann J.M., Quiroz M., Maki R., and Teitelbaum S.L. Osteopetrosis in mice lacking hematopoietic transcription factor PU.1. Nature 386 (1997) 81-84
28. Steidl U., Rosenbauer F., Verhaak R.G., Gu X., Ebralidze A., Otu H.H., Klippel S., Steidl C., Bruns I., Costa D.B., Wagner K., Aivado M., Kobbe G., Valk P.J., Passegue E., Libermann T.A., Delwel R., and Tenen D.G. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat. Genet. 38 (2006) 1269-1277
29. Rosenbauer F., and Tenen D.G. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev., Immunol. 7 (2007) 105-117
30. Dahl R., and Simon M.C. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Blood Cells Mol. Dis. 31 (2003) 229-233
31. Adolfsson J., Mansson R., Buza-Vidas N., Hultquist A., Liuba K., Jensen C.T., Bryder D., Yang L., Borge O.J., Thoren L.A., Anderson K., Sitnicka E., Sasaki Y., Sigvardsson M., and Jacobsen S.E. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121 (2005) 295-306